Feeds
Cedars-Sinai Medical CenterStem Cell/Bone Marrow Transplant Program8700 Beverly Boulevard Room AC-1060 Los Angeles, CA 90048 Direct phone: (310) 423-5351 Toll-free phone: (800) 265-4186 http://www.cedars-sinai.edu/bloodmarrow |
Program Description: |
The program was established in 1989 and has since performed over 1,000 transplants using advanced knowledge and technology. The Cedars-Sinai Blood and Marrow Transplant Program offers coordinated, multidisciplinary, state-of-the-art cancer services for patients.
|
||||||||||
Contact Information: |
If you have transplant-related questions, please contact Patricia Van Strien, transplant center coordinator, at (310) 423-5351 or by e-mail at patricia.vanstrien@cshs.org. |
||||||||||
Program Type: |
Adult (ages 18 to 75) |
||||||||||
Attending Physicians:(Medical Doctors) |
Adult -Michael Lill, Stephen Lim, Angela Lopez, Amir Steinberg |
||||||||||
Transplants Performed: |
Marrow/PBSC, single cord, and double cord |
||||||||||
Cord blood transplants performed on: |
Adult only |
||||||||||
Mismatches allowed:For marrow, PBSC, or cord blood transplant with an unrelated donor. Match criteria may vary based on patient's age, disease type and stage. |
|
||||||||||
Explain Transplant Center HLA Match Requirements
Estimated Search & Transplant Costs |
|
| Costs vary greatly from center to center, and depend on factors such as health insurance, disease type, and disease stage of the patient, as well as center-specific billing policies. | |
| Activation of formal search | $850 - 932 |
| DR testing of A/B tested donors (per donor) | $395 - 708 |
| Confirmatory typing blood sample (per sample) | $365 - 708 |
| IDM sample collection/testing (per donor) | $225 - 6,247 |
| High resolution - HLA typing | $435 - 752 |
| Marrow or PBSC procurement | $26,300 - 76,969 |
| Cord blood procurement (including shipping fees) | $33,220 - 76,969 |
| Cord blood typing | $570 - 708 |
|
The costs listed above are only a small part of the total cost of a transplant. Contact your transplant center to learn more about costs of actual transplant and follow-up treatment. |
|
Explain Transplant Costs at Different Centers
Financial Services:Financial services at this center could include:
|
Resources for financial informationIf you have questions about costs and financial services at this transplant center, you can contact the center's financial representative, Kimberly Munson at (310) 423-2684 or by e-mail at kimberly.munson@cshs.org. Many organizations exist to help patients with lodging, transportation and other transplant-related expenses. Visit the National Marrow Donor Program's Patient Organizations database for more information. Financial assistance resources are also listed on this Web site. |
Transplant Experience |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This center has been performing allogeneic transplants since
1996 and has been an NMDP transplant center since September 2001.
This center performed a total of 115 transplants, all types, in the most recent year (from June 2008 to May 2009) *The total Non-Myeloblative transplants column shows a subset of the total number of transplants by type. To locate centers that perform cord blood transplants, use the search tool on this site. The NMDP also has Transplants by Disease Charts available showing the number of NMDP coordinated transplants by disease category at each U.S. transplant center. Center-Specific Analysis (Using unrelated NMDP donors)This analysis is based on transplants performed from Jan. 1, 2003 through Dec. 31, 2007, using unrelated NMDP donors. It only includes patients who were confirmed to be either alive or deceased within one year of transplant.
For help with understanding these statistics, please see How to Understand NMDP Transplant Center Statistics. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Survival by Patient's Age, Disease Type and Stage (Using unrelated NMDP donors)
This data is only based on unrelated transplants performed from Jan. 2003 to Dec. 2007. It also includes one year post-transplant follow-up, through Dec. 2008. The first number represents the number of patients alive at one year post transplant. The second number is a total number of transplanted patients in that particular group.
| CP = chronic phase (1st or 2nd) | BP = blastic phase |
| AP = accelerated phase | CR = complete remission (1st, 2nd, 3rd or more) |
| RLPS = relapse | PIF = primary induction failure |
Diagnoses |
0-10 |
11-17 |
18-30 |
31-40 |
41-50 |
51-60 |
> 60 |
Overall |
| Acute Lymphoblastic Leukemia 1CR | -- | -- | -- | -- | 0/1 | 0/1 | -- | 0/2 |
| Acute Lymphoblastic Leukemia RLPS | -- | -- | 0/2 | -- | -- | -- | -- | 0/2 |
| Acute Myelogenous Leukemia 2CR | -- | -- | 0/1 | 1/1 | -- | -- | -- | 1/2 |
| Acute Myelogenous Leukemia 3+CR/RLPS | -- | -- | -- | 0/1 | 0/2 | -- | -- | 0/3 |
| Chronic Lymphocytic Leukemia | -- | -- | -- | -- | -- | 1/1 | -- | 1/1 |
| Hodgkin's Disease | -- | -- | 1/2 | 0/1 | -- | -- | -- | 1/3 |
| MDS-Refractory Anemia-Excess Blasts | -- | -- | -- | -- | 0/1 | -- | -- | 0/1 |
| Myelofibro Myeloid Metaplasia | -- | -- | -- | -- | -- | 1/1 | -- | 1/1 |
| Non-Hodgkin's Lymphoma | -- | -- | -- | 0/1 | 0/1 | 0/1 | -- | 0/3 |
| Prolymphocytic Leukemia | -- | -- | -- | -- | -- | 0/1 | -- | 0/1 |
| Severe Aplastic Anemia | -- | -- | 1/1 | 1/1 | -- | -- | -- | 2/2 |
| Total | -- | -- | 2/6 | 2/5 | 0/5 | 2/5 | -- | 6/21 |
Explain Survival by Patient Diagnosis and Age
BMT InfoNet (Blood & Marrow Transplant Information Network) is a nonprofit organization that provides information and emotional support to transplant patients and their families.
